CD79A and Miyoshi myopathy: Of these, 38 cases carried novel N-glycosylation sequons introduced by SHM, again with no significant differences in frequency between IgA MM (8/23 cases, 34.8%) versus IgG MM (30/70 cases, 42.8%) (Supplemental Table 11).